TrialThe Lancet. Oncology2021

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.

David J Pinato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.